Off-Target Serine/Threonine Kinase 10 Inhibition by Erlotinib Enhances Lymphocytic Activity Leading to Severe Skin Disorders

Naoko Yamamoto(Disco (japan)), Hiroshi Suzuki(Obayashi (Japan)), Masashi Honma(University of Tokyo Hospital)
Molecular Pharmacology
May 24, 2011
Cited by 44


Related Papers